Capital Fund Management (CFM)’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,600
Closed -$389K 1563
2021
Q3
$389K Buy
+12,600
New +$356K ﹤0.01% 1418
2016
Q2
Sell
-7,800
Closed -$267K 1488
2016
Q1
$267K Buy
+7,800
New +$308K ﹤0.01% 1355
2013
Q4
Sell
-8,900
Closed -$299K 1636
2013
Q3
$299K Sell
8,900
-123,900
-93% -$4.03M ﹤0.01% 1363
2013
Q2
$3.81M Buy
+132,800
New +$3.87M 0.06% 433

Other funds holding ALKS

Capital Fund Management (CFM)'s ALKS Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its Alkermes (ALKS) stake by 61% in Q1 2026, buying an estimated $2.86M and bringing the position to 243,043 shares worth $8.59M. The position accounts for 0.04% of the portfolio, ranked #622.

Capital Fund Management (CFM) first reported a position in ALKS in Q2 2013 and has held it in 39 quarters since. The position peaked at $18.8M in Q1 2016. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Capital Fund Management (CFM) held 243,043 shares of Alkermes worth $8.59M as of Q1 2026.
  • Capital Fund Management (CFM) bought 92,268 Alkermes shares in Q1 2026, an estimated $2.86M.
  • Alkermes made up 0.04% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #622 holding.
  • Capital Fund Management (CFM) first reported a position in Alkermes in Q2 2013 and has held it in 39 quarters since.
  • Capital Fund Management (CFM)'s Alkermes position peaked at $18.8M in Q1 2016.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.